ReShape Lifesciences Inc. company info

CIK 1371217
IRS Number 481293684
State of incorporation DE
Business address 1001 CALLE AMANECER
Mail address 1001 CALLE AMANECER

Short summary

ReShape Lifesciences Inc. is a California company, with head office located at 1001 Calle Amanecer San Clemente, California 92673. In 2018 the company owned a total of 43.69 million USD worth of assets, including 12.63 million USD worth of current assets. 2017 was the year when the company amassed the most assets.

ReShape Lifesciences Inc. Income Statement

Name [in Millions USD]20022003200420052006200720082009201020112012201320142015201620172018Trends
Cost of Goods and Services Sold 0.330.16
Gross Profit
Selling, General and Administrative Expense 8.637.688.5811.9613.6614.5619.8917.9825.9819.26
Research and development 15.588.5016.6710.6711.0811.
Operating Expenses 24.2116.1825.2622.6324.7325.5928.0323.1528.2938.99
Operating Income (Loss) -16.18-25.26-22.55-24.73-25.59-27.87-22.80-31.41-38.55
Interest expense 0.03
Other Nonoperating Income (Expense) -0.05-0.08-0.03-0.02-0.12-
Income Tax Expense (Benefit) -2.31-3.45
Net income -0.60-1.90-3.45-11.22-17.69-28.58-37.87-31.93-17.35-26.00-23.46-25.78-26.13-25.50-23.36-33.82-81.15

ReShape Lifesciences Inc. Balance Sheet

Name [in Millions USD]20022003200420052006200720082009201020112012201320142015201620172018Trends
Cash and cash equivalents 21.0610.0827.2126.5523.0921.674.8011.5211.201.864.36
Available-for-sale Securities, Current 1.000
Accounts Receivable, Net, Current
Inventories 1.091.360.901.281.961.422.100.98
Property, Plant and Equipment, Gross 2.502.682.822.912.952.963.403.20
Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment 1.872.072.242.432.622.762.973.14
Goodwill 6.4027.19
Other Assets, Noncurrent 0.130.381.051.000.930.610.730.080.56
Total assets 29.0730.5226.8824.417.8814.9942.5250.5143.69
Current assets 28.3329.4925.2722.916.5314.1213.265.3312.63
Accounts payable
Total current liabilities 4.694.758.268.816.4510.304.518.7012.15
Long-term Debt 4.70
Deferred income taxes 5.291.26
Total liabilities 8.6413.3313.049.746.4518.604.5111.4030.30
Common Stock, Value, Issued 0.280.400.560.690.740.
Retained Earnings (Accumulated Deficit) -161.36-187.30-213.08-240.19-266.66-289.98-315.15-385.09-439.39
Accumulated Other Comprehensive Income (Loss), Net of Tax 0.00

ReShape Lifesciences Inc. Cash Flow

Name [in Millions USD]20022003200420052006200720082009201020112012201320142015201620172018Trends
Net income -0.60-1.90-3.45-11.22-17.69-28.58-37.87-31.93-17.35-26.00-23.46-25.78-26.13-25.50-23.36-33.82-81.15
Depreciation and amortization
Depreciation 0.420.380.300.230.17
Amortization of Intangible Assets 0.080.20
Deferred Income Tax Expense (Benefit) -2.31-3.45
Accounts receivable 0.05-0.03-
Inventories 1.070.20-0.14-0.150.710.100.18-1.98
Accounts payable -0.07-0.110.37-
Net Cash Provided by (Used in) Operating Activities -24.66-13.66-19.94-22.48-18.43-22.61-20.66-24.59-27.49
Payments to Acquire Property, Plant, and Equipment
Payments to Acquire Businesses, Net of Cash Acquired 1.85
Net Cash Provided by (Used in) Investing Activities 5.04-6.535.070.92-0.22-0.04-0.01-6.37-10.33
Net Cash Provided by (Used in) Investing Activities, Continuing Operations 0.92-0.22-0.09-0.04-0.01-1.99-10.33
Proceeds from Issuance of Common Stock 1134.5033.20
Net Cash Provided by (Used in) Financing Activities 13.1836.4212.5215.3819.6318.9516.0537.8133.20
Cash and Cash Equivalents, Period Increase (Decrease) -6.4416.22-2.35-6.180.99-11.68-3.69-4.626.85